GH Research (GHRS) Accumulated Expenses (2020 - 2025)
GH Research's (GHRS) quarterly Accumulated Expenses came in at $3.3 million in Q4 2025, down 13.65% year-on-year from $3.9 million in Q4 2024, and down 13.65% quarter-over-quarter from $3.9 million in Q4 2024.
GH Research (GHRS) Accumulated Expenses (2020 - 2025) Analysis & Trends
GH Research's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $3.3 million for Q4 2025.
- On a quarterly basis, Accumulated Expenses fell 13.65% year-over-year to $3.3 million in Q4 2025; TTM through Dec 2025 was $3.3 million, a 13.65% decrease from a year earlier, with the FY2025 full-year figure at $3.3 million, down 13.65% from the prior year.
- Accumulated Expenses slipped to $3.3 million in Q4 2025 per GHRS's latest filing, from $3.9 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $3.9 million in Q4 2024 and bottomed at $1.7 million in Q4 2021.
- The 5-year median for Accumulated Expenses is $2.4 million (2022), against an average of $2.7 million.
- Across the five-year window, Accumulated Expenses surged 601.65% in 2021 and slipped 13.65% in 2025, its largest moves.
- Year by year, Accumulated Expenses stood at $1.7 million in 2021, then soared by 39.34% to $2.4 million in 2022, then dropped by 1.73% to $2.3 million in 2023, then jumped by 66.37% to $3.9 million in 2024, then retreated by 13.65% to $3.3 million in 2025.
- Per Business Quant, the three latest GHRS Accumulated Expenses figures stand at $3.3 million (Q4 2025), $3.9 million (Q4 2024), and $2.3 million (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | GH Research | 1.69 Bn | 1.69 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.34 Mn |
| Dec 31, 2024 | 3.87 Mn |
| Dec 31, 2023 | 2.33 Mn |
| Dec 31, 2022 | 2.37 Mn |
| Dec 31, 2021 | 1.70 Mn |
| Dec 31, 2020 | 242,000.00 |